← Leaderboards
Teiji Sawa
Intermune Pharmaceuticals, Inc.
$208,842
Attributed
$208,842
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$208,842 · 1
By mechanism
R41$208,842 · 1
Top collaborators
No co-investigators on record.
Most similar at Intermune Pharmaceuticals, Inc.
Same institution · by research overlap
- Edward G Spack$100,000
Others in their field
Top investigators on “Antibacterial Antibody”
- Vance G Fowler · Duke University$46,515,637
- Henry F Chambers · Duke University$46,515,637
- Jorge L. Benach · State University New York Stony Brook$14,770,780
- David S Perlin · Hackensack University Medical Center$11,429,593
- Deborah T Hung · Massachusetts General Hospital$6,594,786
- Lallan Giri · Biologics Resources, Llc$6,089,593
Research focus
Antibacterial AntibodyBacterial PneumoniaBacterial ProteinsBlocking AntibodyChemopreventionDrug Screening /EvaluationHemodynamicsImmunologic Substance Development /PreparationLaboratory RabbitMonoclonal AntibodyPassive ImmunizationPseudomonas AeruginosaRespiratory Gas LevelRespiratory Infections